Plasma protein profiling of Mild Cognitive Impairment and Alzheimer¿s disease using iTRAQ quantitative proteomics

Conclusion:
These findings demonstrate that expression level changes in multiple proteins are observed in MCI and AD plasma. Some of these, such as afamin and IGHM, may be candidate biomarkers for AD and the predementia condition of MCI.

Source: Proteome Science - January 17, 2014 Category: Bioinformatics Authors: Fei SongAnne PoljakNicole KochanMark RafteryHenry BrodatyGeorge SmythePerminder Sachdev Source Type: research